KMG

Alginates for pharmaceutical purposes; antibacterial pharmaceuticals; anti-cancer preparations; biological preparations for the treatment of cancer; medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; topical gel for medical and therapeutic treatment of cancer, arterial bleeding disease